國家生技研究園區赴2022台灣醫療科技展

Congratulations for Director Han-Chung Wu granted 2022 Future Tech Award

【Research】A hybrid mRNA vaccine induced broadly neutralizing antibodies against Omicron and other SARS-CoV-2 variants

【Research】A critical overview of current progress for COVID-19 from teams of Drs. Han-Chung Wu, Wen-Shan Li, Hsing-Pang Hsieh and Mi-Hua Tao published in J. Biomed. Sci.

【20220606】_台斯友好 斯洛伐克訪問團來訪園區

First Test to be Approved for Academia Sinica! A SARS-CoV-2 rapid antigen test developed at Academia Sinica has been granted Emergency Use Authorization by TFDA

亞洲生技大展登場！國家生技研究園區展出六大防疫研發成果

為加強防疫整備應變，本中心感染性疾病核心設施(以下簡稱ID Core)提供新型冠狀病毒深喉嚨唾液PCR檢驗服務

【線上首播立即看！生醫轉譯研究中心專題分享】 ~Covid-19之科研前線與抗疫後盾！~

本園區C棟公用印表機服務公告